Late Relapse in Osteosarcoma
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The aim of this study was to identify predictive factors of late relapse in nonmetastatic osteosarcoma patients treated at the Rizzoli Institute from 1983 to 1997. Clinical features of patients who had late (>4 y of follow-up) or earlier recurrence were compared. Late relapse was reported in 24 (3.7%) of the 648 patients who entered the studies. A surgical complete remission was achieved in 19 (79%) patients. The 5-year probability of postrelapse survival was 65% for the complete remission patients (48% in the entire group), which was significantly better than that of the patients (5-year postrelapse survival 20%) with an early relapse. Sex, site, and size of the tumor, histologic subtype, alkaline phosphatase and lactate dehydrogenase serum levels, type of surgery, and histologic response did not significantly differ between patients with late or early relapse. No clinical predictive factors of late relapse were identified and a prolonged follow-up is recommended for all patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimated Risks of Radiation-Induced Fatal Cancer from Pediatric CT
Brenner, D. J., Elliston, C. D., Hall, E. J., & Berdon, W. E. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.2.1760289 · Cited by 3,222
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · cited 1×
“Tibia 58 (24) 10 (42) Humerus 28 (12) 1 (4) Other 18 (7) 2 (8) SAP* Normal 101 (45) 11 (48) 0.”
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316 · cited 2×
“Tibia 58 (24) 10 (42) Humerus 28 (12) 1 (4) Other 18 (7) 2 (8) SAP* Normal 101 (45) 11 (48) 0.”
BackgroundSelf-citationMeyers, P. A., Gorlick, R., Heller, G., Casper, E., Lane, J., Huvos, A. G., & Healey, J. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2452 · Cited by 294
Ferrari, S., Bacci, G., Picci, P., Mercuri, M., Briccoli, A., Pinto, D., Gasbarrini, A., Tienghi, A., & Brach del Prever, A. (1997) · Annals of Oncology · doi:10.1023/a:1008221713505 · Cited by 116
Self-citation
Cited by
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Ferrari, S., & Palmerini, E. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328122d73f · Cited by 219
Self-citationSafety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
Perrot, P., Rousseau, J., Bouffaut, A.-L., Rédini, F., Cassagnau, E., Deschaseaux, F., Heymann, M.-F., Heymann, D., Duteille, F., Trichet, V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010999 · Cited by 120
“prognostic factor for late relapse (after 4 years) instead of earlier relapse [19,20].”
BackgroundHernigou, P., Flouzat Lachaniette, C. H., Delambre, J., Chevallier, N., & Rouard, H. (2014) · International Orthopaedics · doi:10.1007/s00264-014-2384-0 · Cited by 22
“6 % that appears to conform to the other series in the literature [2, 3, 14, 15, 17, 28, 29, 39] for the main tumours (osteosarcoma, chondrosarcoma, and Ewing sarcoma).”
Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects
Pushpam, D., Garg, V., Ganguly, S., & Biswas, B. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s193363 · Cited by 16
Metadata
- Authors
- Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Cesari, M., Longhi, A., & Bacci, G.
- Venue
- Journal of Pediatric Hematology/Oncology
- Published
- 2006-07
- Volume
- 28
- Issue
- 7
- Pages
- 418-422
- ISSN
- 1077-4114 (ISSN-L)
- OpenAlex
- W2086940068
- Cited by
- 40
- References
- 6
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.